Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | C11B2 | Cytochrome P450 11B2, mitochondrial | P19099 | | 1ca | Structure of human aldosterone synthase, CYP11B2, in complex with deoxycorticosterone | 4dvq | 95.67 | | no data |
2 | CP11A | Cholesterol side-chain cleavage enzyme, mitochondrial | P05108 | CYP11A | hcd | Crystal structure of human CYP11A1 in complex with 20-hydroxycholesterol | 3na1 | 95.54 | | no data |
3 | CP11A | Cholesterol side-chain cleavage enzyme, mitochondrial | P05108 | CYP11A | hc9 | Crystal structure of human CYP11A1 in complex with 22-hydroxycholesterol | 3n9z | 94.92 | | no data |
4 | CP11A | Cholesterol side-chain cleavage enzyme, mitochondrial | P05108 | CYP11A | clr | Crystal structure of human CYP11A1 in complex with cholesterol | 3n9y | 94.82 | | no data |
5 | CP11A | Cholesterol side-chain cleavage enzyme, mitochondrial | P05108 | CYP11A | 2dc | Crystal structure of human CYP11A1 in complex with 20,22-dihydroxycholesterol | 3na0 | 96.15 | | no data |
6 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | tok | Human Cytochrome P450 17A1 in complex with TOK-001 | 3swz | 97.58 | | no data |
7 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | aer | Human Cytochrome P450 CYP17A1 in complex with Abiraterone | 3ruk | 97.73 | | no data |
8 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | aer | Human steroidogenic cytochrome P450 17A1 mutant A105L with inhibitor abiraterone | 4nkv | 98.57 | | no data |
9 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | 8qd | Human steroidogenic cytochrome P450 17A1 with 3alphaOH-5alpha-abiraterone analog | 5uys | 98.71 | | no data |
10 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | 3nr | Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 nitrile | 6ciz | 97.41 | | no data |
11 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | 3nq | Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 oxime | 6cir | 98.85 | | no data |
12 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | plo | Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate pregnenolone | 4nkw | 98.78 | | no data |
13 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | str | Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate progesterone | 4nkx | 98.41 | | no data |
14 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | 3qz | Human steroidogenic cytochrome P450 17A1 mutant A105L with substrate 17alpha-hydroxyprogesterone | 4nky | 98.71 | | no data |
15 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | 6d7 | Human cytochrome P450 17A1 bound to inhibitors (R)- and (S)- orteronel | 5irq | 96.29 | | no data |
16 | CP17A | Steroid 17-alpha-hydroxylase/17,20 lyase | P05093 | CYP17 S17AH | 3nx | Human Cytochrome P450 17A1 in complex with inhibitor: abiraterone C6 amide | 6chi | 98.46 | | no data |
17 | CP19A | Aromatase | P11511 | ARO1 CYAR CYP19 | tes | HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE | 5jkw | 99.29 | | no data |
18 | CP19A | Aromatase | P11511 | ARO1 CYAR CYP19 | asd | Crystal structure of human placental aromatase cytochrome P450 in complex with androstenedione | 3eqm | 99.53 | | no data |
19 | CP19A | Aromatase | P11511 | ARO1 CYAR CYP19 | asd | HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2 | 5jl6 | 99.53 | | no data |
20 | CP19A | Aromatase | P11511 | ARO1 CYAR CYP19 | asd | HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL | 5jkv | 99.53 | | no data |
21 | CP19A | Aromatase | P11511 | ARO1 CYAR CYP19 | asd | Human placental aromatase cytochrome P450 (CYP19A1) refined at 2.75 angstrom | 3s79 | 99.52 | | no data |
22 | CP1A1 | Cytochrome P450 1A1 | P04798 | | hjj | Structure of Human Cytochrome P450 1A1 with Bergamottin | 6dwm | 98.17 | | no data |
23 | CP1A1 | Cytochrome P450 1A1 | P04798 | | aq4 | Structure of Human Cytochrome P450 1A1 with Erlotinib | 6dwn | 97.32 | | no data |
24 | CP21A | Steroid 21-hydroxylase | P08686 | CYP21 CYP21B | str | Crystal Structure of Human Cytochrome P450 21A2 Progesterone Complex | 4y8w | 99.89 | | no data |
25 | CP2A6 | Cytochrome P450 2A6 | P11509 | CYP2A3 | d1g | Microsomal P450 2A6 with the inhibitor N,N-Dimethyl(5-(pyridin-3-yl)furan-2-yl)methanamine bound | 2fdu | 99.59 | | no data |
26 | CP2A6 | Cytochrome P450 2A6 | P11509 | CYP2A3 | 9pl | Human Cytochrome P450 2A6 in complex with Pilocarpine | 3t3r | 100 | | no data |
27 | CP2A6 | Cytochrome P450 2A6 | P11509 | CYP2A3 | 9pl | Human Cytochrome P450 2A6 I208S/I300F/G301A/S369G in complex with Pilocarpine | 3t3q | 99.42 | | no data |
28 | CP2AD | Cytochrome P450 2A13 | Q16696 | | 0qa | Human Cytochrome P450 2A13 in complex with two molecules of 4-(methylnitrosamino)-1-(3-puridyl)-1-butanone | 4eji | 99.87 | | no data |
29 | CP2AD | Cytochrome P450 2A13 | Q16696 | | 0qa | Human Cytochrome P450 2A13 in complex with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) | 4ejh | 99.86 | | no data |
30 | CP2AD | Cytochrome P450 2A13 | Q16696 | | 9pl | Human Cytochrome P450 2A13 in complex with Pilocarpine | 3t3s | 100 | | no data |
31 | CP2C8 | Cytochrome P450 2C8 | P10632 | | mtk | CYP2C8dH complexed with montelukast | 2nni | 91 | | no data |
32 | CP2C8 | Cytochrome P450 2C8 | P10632 | | 9cr | CYP2C8dH complexed with 2 molecules of 9-cis retinoic acid | 2nnh | 96.35 | | no data |
33 | CP2C8 | Cytochrome P450 2C8 | P10632 | | 225 | CYP2C8dH complexed with felodipine | 2nnj | 87.27 | | no data |
34 | CP2C8 | Cytochrome P450 2C8 | P10632 | | tdz | CYP2C8DH COMPLEXED WITH TROGLITAZONE | 2vn0 | 89.32 | | no data |
35 | CP2C9 | Cytochrome P450 2C9 | P11712 | CYP2C10 | flp | Crystal Structure of P4502C9 with Flurbiprofen bound | 1r9o | 95.8 | | no data |
36 | CP2C9 | Cytochrome P450 2C9 | P11712 | CYP2C10 | lsn | Crystal structure of CYP2C9 genetic variant I359L (*3) in complex with multiple losartan molecules | 5x24 | 90.52 | | no data |
37 | CP2C9 | Cytochrome P450 2C9 | P11712 | CYP2C10 | 9w6 | Cytochrome P450 (CYP) 2C9 TCA007 Inhibitor Complex | 5w0c | 86.21 | | no data |
38 | CP2C9 | Cytochrome P450 2C9 | P11712 | CYP2C10 | swf | Structure of human cytochrome P450 CYP2C9 | 1og5 | 88.64 | | no data |
39 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | pn0 | V308E mutant of cytochrome P450 2D6 complexed with prinomastat | 6csd | 98.38 | | no data |
40 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | pn0 | Competitive replacement of thioridazine by prinomastat in crystals of cytochrome P450 2D6 | 3tda | 97.78 | | no data |
41 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | pn0 | Human Cytochrome P450 (CYP) 2D6 - Prinomastat Complex | 3qm4 | 96.99 | | no data |
42 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | qi9 | Human Cytochrome P450 2D6 Quinine Complex | 4wnv | 87.9 | | no data |
43 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | si6 | Human Cytochrome P450 2D6 BACE1 Inhibitor 6 Complex | 4xrz | 98.52 | | no data |
44 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | si5 | Human Cytochrome P450 2D6 BACE1 Inhibitor 5 Complex | 4xry | 94.68 | | no data |
45 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | p6m | Structure of cytochrome P450 2D6 (CYP2D6) BACE1 inhibitor complex | 5tfu | 92.89 | | no data |
46 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | p6u | Structure of cytochrome P450 2D6 (CYP2D6) BACE1 inhibitor complex | 5tft | 89.57 | | no data |
47 | CP2D6 | Cytochrome P450 2D6 | P10635 | CYP2DL1 | qdn | Human Cytochrome P450 2D6 Quinidine Complex | 4wnu | 97.25 | | no data |
48 | CP2E1 | Cytochrome P450 2E1 | P05181 | CYP2E | 9pl | Human Cytochrome P450 2E1 in complex with pilocarpine | 3t3z | 99.86 | | no data |
49 | CP2R1 | Vitamin D 25-hydroxylase | Q6VVX0 | | vd3 | Crystal structure of CYP2R1 in complex with vitamin D3 | 3c6g | 98.42 | | no data |
50 | CP2R1 | Vitamin D 25-hydroxylase | Q6VVX0 | | v2h | Crystal structure of CYP2R1 in complex with 1-alpha-hydroxy-vitamin D2 | 3dl9 | 98.23 | | no data |
51 | CP2R1 | Vitamin D 25-hydroxylase | Q6VVX0 | | d2v | Crystal structure of CYP2R1 in complex with vitamin D2 | 3czh | 97.97 | | no data |
52 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | tpf | Human CYP3A4 bound to an inhibitor fluconazole | 6ma7 | 89.16 | | no data |
53 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | myt | Human CYP3A4 bound to an inhibitor metyrapone | 6ma6 | 86.39 | | no data |
54 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | mwy | Human CYP3A4 bound to a drug substrate | 6ooa | 73.41 | | no data |
55 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | mwv | Human CYP3A4 bound to a drug mibefradil | 6oo9 | 95.59 | | no data |
56 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | mws | Human CYP3A4 bound to a suicide substrate | 6oob | 92.1 | | no data |
57 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | kln | Crystal structure of human P450 3A4 in complex with ketoconazole | 2v0m | 97.88 | | no data |
58 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | dj1 | Crystal structure of human CYP3A4 bound to an inhibitor | 6bdk | 89.98 | | no data |
59 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | d81 | Crystal structure of human CYP3A4 bound to an inhibitor | 6bd8 | 89.58 | | no data |
60 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | d0r | Crystal Structure of the complex between human cytochrome P450 3A4 and desthiazolylmethyloxycarbonyl ritonavir | 3tjs | 80.23 | | no data |
61 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | 8aw | Complex of human CYP3A4 with a desoxyritonavir analog | 4k9x | 83 | | no data |
62 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | 6aw | Complex of CYP3A4 with a desoxyritonavir analog | 4k9v | 89.85 | | no data |
63 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | 08y | Crystal structure of the cysteine depleted CYP3A4 bound to bromoergocryptine | 5vcg | 92.97 | | no data |
64 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | 08y | Crystal structure of the cytochrome P4503A4-bromoergocryptine complex | 3ua1 | 93.47 | | no data |
65 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | str | Crystal structure of cytochrome P450 3A4 bound to progesterone | 5a1r | 48.49 | | no data |
66 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | str | Crystal structure of cytochrome P450 3A4 bound to progesterone and citrate | 5a1p | 48.13 | | no data |
67 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | str | Crystal structure of human cytochrome P450 3A4 | 1w0f | 47.31 | | no data |
68 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | myt | Crystal structure of human cytochrome P450 3A4 | 1w0g | 76.83 | | no data |
69 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | 2qh | Crystal structure of CYP3A4 in complex with an inhibitor | 4ny4 | 87.62 | | no data |
70 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | 08j | Crystal structure of the midazolam-bound human CYP3A4 | 5te8 | 89.89 | | no data |
71 | CP3A4 | Cytochrome P450 3A4 | P08684 | CYP3A3 | d7m | Crystal structure of human CYP3A4 bound to an inhibitor | 6bd5 | 88.46 | | no data |
72 | CP46A | Cholesterol 24-hydroxylase | Q9Y6A2 | CYP46 | c3s | Crystal structure of human cytochrome P450 46A1 in complex with cholesterol-3-sulphate | 2q9f | 98.09 | | no data |
73 | CP46A | Cholesterol 24-hydroxylase | Q9Y6A2 | CYP46 | vor | Voriconazole complex of Cytochrome P450 46A1 | 3mdt | 94.82 | | no data |
74 | CP46A | Cholesterol 24-hydroxylase | Q9Y6A2 | CYP46 | fvx | Crystal Structure of Human Cytochrome P450 CYP46A1 with Fluvoxamine Bound | 4enh | 98.55 | | no data |
75 | CP51A | Lanosterol 14-alpha demethylase | Q16850 | CYP51 | vfv | HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP | 4uhi | 95.96 | | no data |
76 | CP51A | Lanosterol 14-alpha demethylase | Q16850 | CYP51 | kkk | Crystal structure of human lanosterol 14alpha-demethylase (CYP51) in complex with ketoconazole | 3ld6 | 88.89 | | no data |
77 | CP51A | Lanosterol 14-alpha demethylase | Q16850 | CYP51 | ecn | Crystal structure of human lanosterol 14alpha-demethylase (CYP51) in complex with econazole | 3jus | 93.14 | | no data |
78 | CP51A | Lanosterol 14-alpha demethylase | Q16850 | CYP51 | ecl | Crystal structure of human lanosterol 14alpha-demethylase (CYP51) in complex with econazole | 3jus | 95.4 | | no data |
79 | CP7A1 | Cholesterol 7-alpha-monooxygenase | P22680 | CYP7 | k2b | Crystal structure of human CYP7A1 in complex with cholest-4-en-3-one | 3sn5 | 97.96 | | no data |
80 | CP7A1 | Cholesterol 7-alpha-monooxygenase | P22680 | CYP7 | 0gv | Crystal structure of human CYP7A1 in complex with 7-ketocholesterol | 3v8d | 98.01 | | no data |
81 | PTGIS | Prostacyclin synthase | Q16647 | CYP8 CYP8A1 | mxd | Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil | 3b6h | 91.1 | | no data |